Ambrosia - SupHerb Ltd.   Report issue

For profit
Founded: Netanya Israel (1986)
Status: No NME R&D (1986)

Organization Overview

First Clinical Trial
2005
NCT00312910
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Ambrosia LLC | Ambrosia - SupHerb Ltd.

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 4
  • # of Trial APIs: 4